Riad El-Dada

Direktor/Vorstandsmitglied bei Merck Sharp & Dohme (Holdings) Pty Ltd.

59 Jahre

Health Technology

Consumer Services

Miscellaneous

Aktive Positionen von Riad El-Dada

Unternehmen	Position	Beginn	Ende
Merck Sharp & Dohme (Holdings) Pty Ltd. Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
MALLINCKRODT PLC	Direktor/Vorstandsmitglied	16.06.2022	14.11.2023
MALLINCKRODT PLC	Independent Dir/Board Member	16.06.2022	14.11.2023
VIRALYTICS LTD.	Direktor/Vorstandsmitglied	20.06.2018	-

Cornell University	Undergraduate Degree
Georgetown University	Graduate Degree

International

Operativ

Director/Board Member	3
Independent Dir/Board Member	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
MALLINCKRODT PLC	Health Technology

Private Unternehmen	2
Viralytics Pty Ltd. Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia.	Health Technology
Merck Sharp & Dohme (Holdings) Pty Ltd. Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia.	Miscellaneous

Private Unternehmen

Health Technology

Miscellaneous